Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Symptom improvement
RCT	26 men In review	Median score improvement in the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) for pain –7 with mepartricin –2 with placebo	P = 0.009	Effect size not calculated	mepartricin
RCT	26 men In review	Median score improvement in the total NIH-CPSI score –15 with mepartricin –5 with placebo	P = 0.0018	Effect size not calculated	mepartricin
RCT	26 men In review	Median score improvement in the NIH-CPSI for urinary dysfunction –5 with mepartricin –4 with placebo	P = 0.2891		Not significant